Information Provided By:
Fly News Breaks for May 8, 2018
ALXN
May 8, 2018 | 11:34 EDT
Jefferies analyst Eun Yang reported that the European Patent Office's Examining Division issued a rejection to Alexion's new Composition of Matter, or CoM, patent application for Soliris. If one is not issued, a potential biosimilar entry is likely in about 2020 in the EU, added Yang, who noted that the company has requested oral proceedings, which are set to take place in February 2019. The analyst has a Hold rating on Alexion.
News For ALXN From the Last 2 Days
There are no results for your query ALXN
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.